sodium bisulfide has been researched along with Ischemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danyaei, A; Hoseinynejad, K; Mard, SA; Sameri, MJ; Savari, F | 1 |
| Chu, W; Li, J; Li, Q; Tu, F; Wang, J | 1 |
| Cai, WJ; Chen, Y; Ding, YJ; Li, N; Wang, MJ; Zhu, YC | 1 |
| Henderson, PW; Jimenez, N; Krijgh, DD; Reiffel, AJ; Ruffino, J; Sohn, AM; Spector, JA; Weinstein, AL | 1 |
4 other study(ies) available for sodium bisulfide and Ischemia
| Article | Year |
|---|---|
The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1.
Topics: Animals; Exosomes; Humans; Ischemia; Liver; Male; Mesenchymal Stem Cells; Mice; Reperfusion Injury; RNA, Long Noncoding | 2022 |
Hydrogen sulfide protects against cognitive impairment induced by hepatic ischemia and reperfusion via attenuating neuroinflammation.
Topics: Animals; Calcium-Binding Proteins; Cognition Disorders; Cytokines; Disease Models, Animal; Hippocampus; Injections, Intraperitoneal; Ischemia; Liver Diseases; Male; Microfilament Proteins; Neurologic Examination; Neuroprotective Agents; Rats, Sprague-Dawley; Reperfusion Injury; Sulfides; Treatment Outcome | 2016 |
The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia.
Topics: Animals; Cell Communication; Endothelial Cells; Extremities; Hemodynamics; Hydrogen Sulfide; Ischemia; Male; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Sulfides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Therapeutic delivery of hydrogen sulfide for salvage of ischemic skeletal muscle after the onset of critical ischemia.
Topics: Animals; Apoptosis; Cell Hypoxia; Cell Line; Critical Illness; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hindlimb; Injections, Intravenous; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myoblasts, Skeletal; Reperfusion Injury; Severity of Illness Index; Sulfides; Time Factors | 2011 |